Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

A simple vitamin could hold the key to treating a rare genetic disorder. Researchers found that vitamin B12 largely reversed developmental defects in worms carrying a mutation linked to Verheij syndrome — a rare condition causing growth delays and short stature. Similar metabolic disruptions were also identified in human patients, hinting that this everyday vitamin could one day inspire new treatments for rare genetic diseases.
Could a common vitamin treat a rare genetic disorder?
Scientists at the Max Planck Institute for Biology of Ageing made a surprising discovery: vitamin B12 can largely reverse developmental defects in C. elegans worms carrying a mutation linked to Verheij syndrome — a rare human condition that causes developmental delays, impaired growth, and short stature. The mutation disrupts RNA splicing, a critical process that helps cells produce proteins correctly, and in turn throws off metabolic pathways that depend on vitamin B12.
When researchers supplemented the worms with extra B12, the affected metabolic processes normalized and developmental abnormalities were corrected. Crucially, analysis of human patient blood samples revealed similar metabolic disruptions, suggesting the same pathways may be at play in people with Verheij syndrome.
Key Takeaways:
Why it matters: This research highlights how metabolic disruptions may be an underappreciated driver of RNA splicing disorders — and that a widely available, low-cost vitamin could potentially become a therapeutic tool for rare genetic diseases.